Data science

Root, Inc. Announces 2022 Second Quarter Results; Moving Forward with Reverse Stock Split at 1-for-18 Ratio

Retrieved on: 
Monday, August 8, 2022 - 9:17pm

Roots second quarter results and management commentary can be found by accessing the shareholder letter posted to the companys investor relations website at ir.joinroot.com .

Key Points: 
  • Roots second quarter results and management commentary can be found by accessing the shareholder letter posted to the companys investor relations website at ir.joinroot.com .
  • Webcast and Conference Call Details:
    Additionally, Root announced today that it will proceed with a 1-for-18 reverse stock split previously approved by Root stockholders at the annual meeting of shareholders on June 7, 2022.
  • No fractional shares will be issued in connection with the reverse stock split.
  • Additional information concerning the reverse stock split can be found in Roots definitive proxy statement filed with the Securities and Exchange Commission on April 28, 2022.

Bain & Company and Trinity Life Sciences announce strategic partnership

Retrieved on: 
Monday, August 8, 2022 - 6:54pm

BOSTON, Aug. 8, 2022 /PRNewswire/ -- Bain & Company, a top global management consultancy, and Trinity Life Sciences, a leader in global life sciences commercialization solutions, have announced a strategic partnership to bring together Bain's extensive global experience across the life sciences value chain with Trinity's deep technical expertise in biopharma and medtech. The partnership includes Bain & Company taking a minority investment in Trinity.

Key Points: 
  • The partnership pairs Bain's extensive experience across the global life sciences value chain with Trinity's specialized, evidence-based solutions for life sciences companies
    BOSTON, Aug. 8, 2022 /PRNewswire/ -- Bain & Company, a top global management consultancy,and Trinity Life Sciences , a leader in global life sciences commercialization solutions, have announced a strategic partnership to bring together Bain's extensive global experience across the life sciences value chain with Trinity's deep technical expertise in biopharma and medtech.The partnership includes Bain & Company taking a minority investment in Trinity.
  • "This partnership feels like a perfect match as we continue to expand and deepen our client offerings," said David Fitzhenry , CEO of Trinity Life Sciences.
  • "The collaboration between Bain & Company and Trinity offers unparalleled breadth and depth in commercial strategy, powered by strong data analytics," said Matt Jennings ,operating partner of Kohlberg & Co and chairman of Trinity Life Sciences.
  • Trinity Life Sciencesis a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences.

Evolytics Ranks #58 on Fortune’s 2022 List of Best Small Workplaces™

Retrieved on: 
Monday, August 8, 2022 - 5:55pm

Today, Fortune and Great Place to Work announced that Evolytics is one of the 2022 Best Small Workplaces, ranking #58 on this years prestigious list.

Key Points: 
  • Today, Fortune and Great Place to Work announced that Evolytics is one of the 2022 Best Small Workplaces, ranking #58 on this years prestigious list.
  • This is the third consecutive year for Evolytics to receive this honor, also making Fortunes list in 2021 and 2020.
  • The Fortune Best Small Workplaces list is highly competitive.
  • In addition to its inclusion on the Fortune Best Small Workplaces list in 2020, 2021 and 2022, Evolytics was also honored by Great Place to Work on its 2021 list of Best Workplaces in Consulting & Professional Services.

DeepIntent Names Amit Chaturvedi as Chief Operating Officer

Retrieved on: 
Monday, August 8, 2022 - 1:00pm

NEW YORK, Aug. 8, 2022 /PRNewswire/ -- DeepIntent, the leading healthcare advertising technology company built to influence better patient health and business outcomes, today announced the appointment of Amit Chaturvedi as its first Chief Operating Officer.

Key Points: 
  • NEW YORK, Aug. 8, 2022 /PRNewswire/ -- DeepIntent , the leading healthcare advertising technology company built to influence better patient health and business outcomes, today announced the appointment of Amit Chaturvedi as its first Chief Operating Officer.
  • Chaturvedi joins DeepIntent with more than two decades of operating experience in advertising technology startups and global media companies.
  • As DeepIntent's first Chief Operating Officer, Chaturvedi will be responsible for the overall business operations of DeepIntent and report directly to the company's founder and Chief Executive Officer, Chris Paquette.
  • With the right people, unique technology, and a clear vision for the future, DeepIntent will continue to lead the shift toward programmatic in pharma," Chaturvedi said.

Parsons and Aurora Insight Partner to Advance Commercial Space Solutions for Military Operations

Retrieved on: 
Monday, August 8, 2022 - 12:25pm

CENTREVILLE, Va., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN), a leader in the global defense, intelligence, and space markets, announced today the addition of Aurora Insight as a strategic partner for commercial space research, development, and mission exploration and advancement.

Key Points: 
  • CENTREVILLE, Va., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN), a leader in the global defense, intelligence, and space markets, announced today the addition of Aurora Insight as a strategic partner for commercial space research, development, and mission exploration and advancement.
  • Our continued partnership with Aurora, who is equally focused on delivering innovative, rapid, affordable, operational space solutions will protect global security and transform all-domain operations for our warfighters, said Mike Kushin, Parsons executive vice president of High Consequence Missions.
  • Auroras innovative space-based RF capabilities paired with Parsons mission-focused solutions are truly disruptive to the next generation of commercial space information warfare.
  • Aurora Insight is excited to collaborate with a world class company like Parsons, said Aurora Insight CEO Jennifer Alvarez.

Initial Analysis of Tumor Profiling From a Prospective Study by Foundation Medicine, Flatiron Health and Genentech Demonstrates Value of Tissue and Liquid Comprehensive Genomic Profiling in Patients with Advanced Non-Small Cell Lung Cancer

Retrieved on: 
Monday, August 8, 2022 - 12:05pm

At study enrollment, patients with non-squamous aNSCLC received Foundation Medicines liquid biopsy CGP testing, and a subset also received Foundation Medicine tissue testing.

Key Points: 
  • At study enrollment, patients with non-squamous aNSCLC received Foundation Medicines liquid biopsy CGP testing, and a subset also received Foundation Medicine tissue testing.
  • In particular, Foundation Medicine's liquid biopsy test detected guideline-recommended biomarkers in 48 additional patients who received single biomarker or hotspot testing.
  • Results from this research reinforce the unique benefits, and complementary value of both tissue- and blood-based CGP tests, depending on the patients tissue availability, health status and tumor type.
  • This research reinforces how advances in precision oncology are benefitting patients with advanced non-small cell lung cancer."

ADM and Benson Hill Partner to Scale Innovative Ultra-High Protein Soy for North American Food Ingredient Markets

Retrieved on: 
Monday, August 8, 2022 - 11:55am

The partnership will serve a variety of plant-based food and beverage markets to meet savory, sweet and dairy customer needs.

Key Points: 
  • The partnership will serve a variety of plant-based food and beverage markets to meet savory, sweet and dairy customer needs.
  • View the full release here: https://www.businesswire.com/news/home/20220808005188/en/
    ADM and Benson Hill, Inc., today announced a long-term strategic partnership to scale innovative soy ingredients that will help meet the rapidly growing demand for plant-based proteins.
  • (Photo: Business Wire)
    Through the collaboration, ADM will process and commercialize a portfolio of proprietary ingredients derived from Benson Hill Ultra-High Protein (UHP) soybeans through an exclusive North American licensing partnership.
  • ADM and Benson Hill expressly disclaim any duty to update these forward-looking statements, except as otherwise required by law.

ADM and Benson Hill Partner to Scale Innovative Ultra-High Protein Soy for North American Food Ingredient Markets

Retrieved on: 
Monday, August 8, 2022 - 11:55am

The partnership will serve a variety of plant-based food and beverage markets to meet savory, sweet and dairy customer needs.

Key Points: 
  • The partnership will serve a variety of plant-based food and beverage markets to meet savory, sweet and dairy customer needs.
  • View the full release here: https://www.businesswire.com/news/home/20220808005132/en/
    ADM and Benson Hill, Inc., today announced a long-term strategic partnership to scale innovative soy ingredients that will help meet the rapidly growing demand for plant-based proteins.
  • (Photo: Business Wire)
    Through the collaboration, ADM will process and commercialize a portfolio of proprietary ingredients derived from Benson Hill Ultra-High Protein (UHP) soybeans through an exclusive North American licensing partnership.
  • ADM and Benson Hill expressly disclaim any duty to update these forward-looking statements, except as otherwise required by law.

Klaytn Spearheads World's Largest Blockchain Research Center Program in Collaboration with Top-Ranking Universities KAIST and NUS

Retrieved on: 
Monday, August 8, 2022 - 10:29am

BRC is a virtual research institute that aims to advance cutting-edge research for blockchain technology, deepen blockchain capabilities, and support industry growth.

Key Points: 
  • BRC is a virtual research institute that aims to advance cutting-edge research for blockchain technology, deepen blockchain capabilities, and support industry growth.
  • With a US$20m funding commitment from Klaytn over the next four years, BRC is to date the world's largest blockchain research center program in terms of known funding size.
  • Through our BRC program, in collaboration with leading minds from KAIST and NUS, we are delighted to take the next step in bringing our vision to life."
  • Dr Kang said, "Our world-class blockchain researchers at the Blockchain Research Center will contribute to the seven pillars of blockchain research: consensus, privacy, network, smart contracts, DeFi, economics/ethics, and metaverse.

Clark Atlanta University awarded $10 Million National Science Foundation grant to bring Data Science to HBCUs through National Data Science Alliance (NDSA)

Retrieved on: 
Friday, August 5, 2022 - 12:49pm

To accomplish this visionary goal, the NDSA will facilitate engagement across all HBCUs with industry and academic collaboration to broaden participation and advance social justice in data science.

Key Points: 
  • To accomplish this visionary goal, the NDSA will facilitate engagement across all HBCUs with industry and academic collaboration to broaden participation and advance social justice in data science.
  • As the Director of the Atlanta University Center (AUC) Data Science Initiative and professor of mathematics at Clark Atlanta University, she is passionate about engaging more HBCUs and building a community to accelerate the preparation of students in data science and discover solutions for data-oriented problems that impact the lives of Blacks.
  • "We are excited that many HBCUs will collaborate with us to develop new equity-based discoveries in data science and expand student pathways that will change the face of data science," said Washington.
  • The NDSA's three regional hubs are led by LaTanya Brown-Robertson (Howard University), Sajid Hussain (Fisk University), and Eric Mintz (Clark Atlanta University).